Addus HomeCare Corporation (ADUS) - Stock Analysis

Last updated: Apr 11, 2026

HealthcareClosed

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release.

Loading chart data...

Idea window: 10/20/2025 – 10/27/2025Sector: Healthcare

AI Analyst Overview

Last Price
$93.17
Market Cap
$1.72B
1D Return
+1.04%
YTD Return
-13.24%

Loading chart data...

Valuation Metrics

P/E
17.7
P/B
1.6
P/S
1.2
EV/EBITDA
12.1
Div Yield
—

Fundamental Analysis

7.0

Key Financial Insights: • Positive free cashflow • High intangibles • Conservative leverage ADUS generates steady FCF and conservative leverage with improving margins, but large intangibles and receivables pose concentration and credit risks that constrain upside.

CashGenerative
IntangibleRisk

Price Behavior

6.0

Key Price Behavior Insights: • Lower-highs trend • Support test held • ~9% from high Support Level: $91.59 Resistance Level: $99.70–$101.60 Stock is in a clear short-term downtrend over the last month, down ~7.6% from $99.74 to $92.21, testing but holding near $91.59 with resistance at $99.70–$101.60—watch for a close back above $99.70 to signal a recovery attempt.

downtrend
watch

Sentiment & News

6.0

Key News Insights: • Aging demographics • AI interest • Institutional repositioning Addus HomeCare faces sector tailwinds from aging demographics and AI interest but is showing short-term share-pressure and active institutional repositioning after a 52-week low.

SectorTailwinds
SharePressure
AI

AI Summary

6.0
Neutral

Addus has evolved into a cash-generative roll-up with improving margins and deleveraging optionality, but the investment now hinges on successful M&A/integration execution and sustaining reimbursement tailwinds while protecting a large intangible asset base from impairment. #M&AExecution‍

CashGeneration
ReimbursementRisk
AI summary updated 1 days ago

Description

Addus HomeCare provides in-home personal care, hospice, and home health services to elderly, chronically ill, disabled people and those at risk of hospitalization in the United States. Its Personal Care unit supplies non-medical assistance with daily living activities, the Hospice unit delivers palliative and family support services, and the Home Health unit offers skilled nursing and rehabilitative therapies. The company contracts with government programs, managed care organizations, commercial insurers and private clients, and as of December 31, 2021 operated 206 offices in 22 states; it was founded in 1979 and is based in Frisco, Texas.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Oct 20Oct 27ADUSAddus HomeCare Corporation
Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release.
Closed+0.0%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.